Abstract:One of the most paramount receptor-induced signal transduction mechanisms in hematopoietic cells is production of the lipid second messenger phosphatidylinositol(3,4,5)trisphosphate (PIP3) by class I phosphoinositide 3 kinases (PI3K). Defective PIP3 signaling impairs almost every aspect of hematopoiesis, including T cell development and function. Limiting PIP3 signaling is particularly important, because excessive PIP3 function in lymphocytes can transform them and cause blood cancers. Here, we review the key functions of PIP3 and related phosphoinositides in hematopoietic cells, with a special focus on those mechanisms dampening PIP3 production, turnover, or function. Recent studies have shown that beyond "canonical" turnover by the PIP3 phosphatases and tumor suppressors phosphatase and tensin homolog (PTEN) and SH2 domain-containing inositol-5-phosphatase-1 (SHIP-1/2), PIP3 function in hematopoietic cells can also be dampened through antagonism with the soluble PIP3 analogs inositol(1,3,4,5)tetrakisphosphate (IP4) and inositol-heptakisphosphate (IP7). Other evidence suggests that IP4 can promote PIP3 function in thymocytes. Moreover, IP4 or the kinases producing it limit store-operated Ca2+ entry through Orai channels in B cells, T cells, and neutrophils to control cell survival and function. We discuss current models for how soluble inositol phosphates can have such diverse functions and can govern as distinct processes as hematopoietic stem cell homeostasis, neutrophil macrophage and NK cell function, and development and function of B cells and T cells. Finally, we will review the pathological consequences of dysregulated IP4 activity in immune cells and highlight contributions of impaired inositol phosphate functions in disorders such as Kawasaki disease, common variable immunodeficiency, or blood cancer.

Review of PIP2 in Cellular Signaling, Functions and Diseases

Review of PIP2 in Cellular Signaling, Functions and Diseases

Striking a balance: PIP2 and PIP3 signaling in neuronal health and disease

Phosphatidylinositol-3,4,5-Triphosphate and Cellular Signaling: Implications for Obesity and Diabetes

Phosphatidylinositol(4,5)bisphosphate: diverse functions at the plasma membrane

PIP kinases and their role in plant tip growing cells

Regulation of Hematopoietic Cell Development and Function Through Phosphoinositides

Inositol Pyrophosphates: Signaling Molecules with Pleiotropic Actions in Mammals

PIP2 AND PROTEINS: Interactions, Organization, and Information Flow

The expanding spectrum of neurological disorders of phosphoinositide metabolism

Phosphatidylinositol 3,4-bisphosphate: Out of the shadows and into the spotlight

The inositol phosphate signalling network in physiology and disease

Phosphatidylinositol 3-monophosphate: A novel actor in thrombopoiesis and thrombosis

Phosphatidylinositol 4,5-bisphosphate and calcium at ER-PM junctions - Complex interplay of simple messengers

Beyond PI3Ks: targeting phosphoinositide kinases in disease

Advances in Subunits of PI3K Class I in Cancer.

Mammalian START-like phosphatidylinositol transfer proteins - Physiological perspectives and roles in cancer biology

Phosphatidylinositol 3‐phosphates—at the interface between cell signalling and membrane traffic

Regulators regulated: Different layers of control for plasma membrane phosphoinositides in plants

Inositolpolyphosphates and their binding proteins--a short review

Drugging the Phosphoinositide 3-Kinase (PI3K) and Phosphatidylinositol 4-Kinase (PI4K) Family of Enzymes for Treatment of Cancer, Immune Disorders, and Viral/Parasitic Infections